Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Effectiveness of Integration of Rapid Antigen Testing for SARS-CoV-2 in MNCH, HIV and TB Services in Cameroon and Kenya: A Pre- and Post- Implementation Evaluation (Effectiveness Study)

NCT05498727 is registered in ClinicalTrials.gov with Elizabeth Glaser Pediatric AIDS Foundation as lead sponsor.

NCT NCT05498727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05498727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Effectiveness of Integration of Rapid Antigen Testing for SARS-CoV-2 in MNCH, HIV and TB Services in Cameroon and Kenya: A Pre- and Post- Implementation Evaluation (Effectiveness Study)
Lead sponsor
Elizabeth Glaser Pediatric AIDS Foundation
Phase
Observational
Overall status
Completed
Start date
May 2, 2022
Completion date
September 30, 2023
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19